MergerLinks - Request Credit - Cell and Gene Therapy Catapult to acquire the vaccine manufacturing business and assets of Benchmark Holdings for $20m.

Submit Deal

Request Deal Involvement

Cell and Gene Therapy Catapult to acquire the vaccine manufacturing business and assets of Benchmark Holdings for $20m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

financial advisors

Deutsche Numis

pr advisors

MHP Communications

legal advisors

Travers Smith

Principals

target

BENCHMARK HOLDINGS PLC (VACCINE MANUFACTURING BUSINESS)

vendor

BENCHMARK HOLDINGS PLC

bidder

CELL AND GENE THERAPY CATAPULT

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.

To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal: